Literature DB >> 1685012

Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.

O E Brodde1, M Khamssi, H R Zerkowski.   

Abstract

To study whether in the (denervated) transplanted human heart beta-adrenoceptors are up-regulated we determined in right ventricular endomyocardial biopsies (weighing 2-7 mg) of 8 heart transplant recipients beta-adrenoceptor density and beta 1:beta 2-adrenoceptor ratio in weekly, later monthly intervals for 6-18 posttransplant months. beta-adrenoceptor density was assessed by 1-2 concentration (-)-[125I]-iodocyanopindolol (ICYP, 200 and 150 pmol/l) binding, the beta 1:beta 2-adrenoceptor ratio by a beta 1-adrenoceptor saturating concentration of the selective beta 1-adrenoceptor antagonist CGP 20712 A (500 nmol/l). In biopsies taken from the donor hearts immediately before transplantation beta-adrenoceptor density was 64.5 +/- 6.3 fmol ICYP bound/mg protein (n = 5), the beta 1:beta 2-adrenoceptor ratio 81.2 +/- 2.2:18.8 +/- 2.2%. beta-Adrenoceptor density did not change during the whole period investigated; it was in the first 9 posttransplant weeks 73.1 +/- 8.3 (n = 22) and after 4-18 months 74.2 +/- 7.6 fmol/mg protein (n = 16). In contrast, with increasing posttransplant time beta 1:beta 2-adrenoceptor ratio was shifted towards beta 2-adrenoceptors: in the first 9 weeks it was 80:20% (n = 17), after 16 weeks 75:25% (n = 10) and after 25-80 weeks 65:35% (n = 7). We conclude that in the first 18 posttransplant months beta-adrenoceptors in the transplanted human heart are not up-regulated. There is, however, a gradual decline in beta 1- and increase in beta 2-adrenoceptors with increasing posttransplant time. As noradrenaline acts in the human heart solely at beta 1-adrenoceptors, while adrenaline activates both beta 1- and beta 2-adrenoceptors with about the same potency, with increasing posttransplant time (and increasing proportion of beta 2-adrenoceptors) adrenaline may play an important role for regulation of contractility and/or heart rate in heart transplant recipients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685012     DOI: 10.1007/bf00172582

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

Review 1.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Cyclosporine, sympathetic activity, and hypertension.

Authors:  A L Mark
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

3.  Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.

Authors:  J D Port; E M Gilbert; P Larrabee; P Mealey; K Volkman; R Ginsburg; R E Hershberger; J Murray; M R Bristow
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

4.  New instrument for transvenous cardiac biopsy.

Authors:  P K Caves; W P Schulz; E Dong; E B Stinson; N E Shumway
Journal:  Am J Cardiol       Date:  1974-02       Impact factor: 2.778

5.  CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptors.

Authors:  D J Dooley; H Bittiger; N C Reymann
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

6.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

7.  Vagal activity is increased during intravenous isoprenaline infusion in man.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

8.  Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin.

Authors:  E M Gilbert; C C Eiswirth; P C Mealey; P Larrabee; C M Herrick; M R Bristow
Journal:  Circulation       Date:  1989-02       Impact factor: 29.690

9.  Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation.

Authors:  K G Lurie; M R Bristow; B A Reitz
Journal:  J Thorac Cardiovasc Surg       Date:  1983-08       Impact factor: 5.209

10.  On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies.

Authors:  S Motomura; H Reinhard-Zerkowski; A Daul; O E Brodde
Journal:  Am Heart J       Date:  1990-03       Impact factor: 4.749

View more
  5 in total

1.  Depletion of endogenous dopamine stores and shift in beta-adrenoceptor subtypes in cardiac tissue following five weeks of chronic denervation.

Authors:  G J Van der Vusse; M L Dubelaar; W A Coumans; M Steinfath; C C Smith; A J Drake-Holland; M I Noble
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

2.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

Authors:  B D Lowes; W Minobe; W T Abraham; M N Rizeq; T J Bohlmeyer; R A Quaife; R L Roden; D L Dutcher; A D Robertson; N F Voelkel; D B Badesch; B M Groves; E M Gilbert; M R Bristow
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  Diminished inhibitory effect of noradrenaline on insulin release from mouse islets transplanted to kidney.

Authors:  C L Shi; I B Täljedal
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

4.  Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy.

Authors:  H Jakob; M Sigmund; T Eschenhagen; U Mende; M Patten; W Schmitz; H Scholz; J Schulte am Esch; M Steinfath; P Hanrath
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Enhanced beta-1 adrenergic receptor responsiveness in coronary arterioles following intravenous stromal vascular fraction therapy in aged rats.

Authors:  Gabrielle Rowe; Natia Q Kelm; Jason E Beare; Evan Tracy; Fangping Yuan; Amanda J LeBlanc
Journal:  Aging (Albany NY)       Date:  2019-07-11       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.